EW - Edwards Lifesciences Corp
Close
75.555
-0.075 -0.099%
Share volume: 76,936
Last Updated: Fri 27 Dec 2024 08:30:08 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$75.63
-0.07
-0.10%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-28 | 2023-02-13 | 2023-04-28 | 2023-07-28 | 2023-10-27 | 2024-02-12 | 2024-04-29 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 8.638 B | 8.293 B | 8.651 B | 9.004 B | 9.371 B | 9.363 B | 9.736 B | 10.099 B | |
| Current Assets | 3.514 B | 3.096 B | 3.257 B | 3.647 B | 4.068 B | 4.036 B | 4.171 B | 4.516 B | |
| Inventories | 757.800 M | 875.500 M | 914.300 M | 980.200 M | 1.032 B | 1.168 B | 1.207 B | 1.025 B | |
| Other Current Assets | 356.000 M | 305.900 M | 309.400 M | 340.600 M | 369.100 M | 386.100 M | 388.700 M | 362.300 M | |
| Short Term Investments | 356.000 M | 305.900 M | 309.400 M | 340.600 M | 369.100 M | 386.100 M | 388.700 M | 362.300 M | |
| Total Receivables | 661.400 M | 699.100 M | 779.300 M | 816.900 M | 802.100 M | 836.900 M | 876.900 M | 834.400 M | |
| Current Cash | 1.739 B | 1.215 B | 1.254 B | 1.509 B | 1.864 B | 1.645 B | 1.698 B | 1.990 B | |
| Total Non-current Assets | 5.124 B | 5.197 B | 5.394 B | 5.357 B | 5.303 B | 5.328 B | 5.566 B | 5.583 B | |
| Property Plant Equipment | 1.566 B | 1.633 B | 1.646 B | 1.662 B | 1.681 B | 1.749 B | 1.768 B | 1.640 B | |
| Other Assets | 316.500 M | 299.100 M | 293.600 M | 412.100 M | 447.400 M | 463.700 M | 767.600 M | 789.800 M | |
| Intangible Assets | 266.500 M | 285.200 M | 446.800 M | 431.400 M | 429.800 M | 428.400 M | 446.800 M | 417.100 M | |
| Goodwill | 1.159 B | 1.164 B | 1.308 B | 1.300 B | 1.297 B | 1.254 B | 1.253 B | 1.151 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 8.638 B | 8.293 B | 8.651 B | 9.004 B | 9.371 B | 9.363 B | 9.736 B | 10.099 B | |
| Total liabilities | 2.420 B | 2.486 B | 2.673 B | 2.628 B | 2.713 B | 2.713 B | 2.618 B | 2.662 B | |
| Total current liabilities | 917.900 M | 1.022 B | 1.082 B | 1.157 B | 1.239 B | 1.195 B | 1.111 B | 1.217 B | |
| Accounts Payable | 154.900 M | 201.900 M | 180.800 M | 193.000 M | 190.600 M | 201.400 M | 212.300 M | 185.900 M | |
| Other liabilities | 839.200 M | 797.600 M | 844.500 M | 740.100 M | 738.000 M | 778.400 M | 764.700 M | 676.200 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 596.200 M | 596.300 M | 596.500 M | 596.700 M | 596.800 M | 597.000 M | 597.200 M | 597.300 M | |
| Other liabilities | 839.200 M | 797.600 M | 844.500 M | 740.100 M | 738.000 M | 778.400 M | 764.700 M | 676.200 M | |
| Minority interest | 0.000 | 0.000 | 84.000 M | 70.800 M | 69.600 M | 69.400 M | 68.500 M | 67.200 M | |
| Total Shareholder equity | 6.218 B | 5.807 B | 5.978 B | 6.376 B | 6.658 B | 6.650 B | 7.118 B | 7.437 B | |
| Common stock | 619.800 M | 613.200 M | 607.500 M | 606.900 M | 607.000 M | 605.400 M | 601.600 M | 602.100 M | |
| Retained earnings | 7.192 B | 7.590 B | 7.931 B | 8.238 B | 8.623 B | 8.992 B | 9.344 B | 9.711 B |